Document is current
Any future updates will be listed below
-
Authors
Polvere, Jacopo http://orcid.org/0000-0002-8345-0546
Fabbiani, Massimiliano
Pastore, Gabiria
Rancan, Ilaria
Rossetti, Barbara
Durante, Miriam
Zirpoli, Sara
Morelli, Enrico
Pettini, Elena
Lucchesi, Simone http://orcid.org/0000-0003-3545-7433
Fiorino, Fabio http://orcid.org/0000-0002-1440-8061
Tumbarello, Mario
Ciabattini, Annalisa
Montagnani, Francesca http://orcid.org/0000-0002-2267-1337
Medaglini, Donata http://orcid.org/0000-0003-1729-7325
- License Information
-
More Information
Article History
Received: 29 June 2022
Accepted: 16 January 2023
First Online: 30 January 2023
Competing interests
: The authors declare the following competing interests. M.F. received speakers’ honoraria, support for travel to meetings, and/or fees for attending advisory boards from Bristol Myers Squibb (BMS), Gilead, Janssen-Cilag, Merck Sharp and Dohme (MSD), and ViiV Healthcare. F.M. received support for travel to meetings from Angelini, she is principal investigator in sponsor study by TLS (Toscana Life Science) and by GSK Vaccine SRL and she is the contact person for a service contract between GSK Vaccine SRL and Department of Medical Biotechnologies, University of Siena, without receiving any personal remuneration. The other authors declare no conflict of interest regarding this study.
